Overview

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

This study of chemotherapy occurred during the neutropenic fever in patients with antibiotic refractory fever. The investigators evaluate efficacy and safety of micafungin sodium (mycamine ® Injection) 100mg dose compare to itraconazole (Sporanox ® Injection) 200mg as a control and this study is prospective, randomized, non-inferiority trials. Therefore, this study was planned for review of the safety and efficacy in korean patients.

Phase:

Phase 2

Details

Lead Sponsor:

Yonsei University

Treatments:

Antifungal Agents
Echinocandins
Hydroxyitraconazole
Itraconazole
Micafungin
Miconazole